ロード中...
Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis
The use of doxorubicin (Dox) was severely constrained by dose-dependent side effects, which might be attenuated by combining a “sensitizer” to decrease its cumulative dosage. In this study, it was investigated whether ocotillol could enhance the antiproliferation activity of Dox. MTT assays and xeno...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3727205/ https://ncbi.nlm.nih.gov/pubmed/23956772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/468537 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|